The discovery of this quadruple (PDGFA–PDGFRA–CREB1–PLAT), capable of distinguishing between grade III and grade IV gliomas, holds substantial implications for patients affected by these tumors. The gene discussed is PLAT; the disease is central nervous system cancer.